Why would oncologist risk rep, malpractice exposure etc. to go with bavi from tiny pphm with their checkered past and botched PII?
Excellent point. So far no credibility for the BOD and mgmt. Their history and track record speak for itself. Carlton Johnson being picked as the COB is still a slap in the face for shareholders. Just shows where ES's priority is imo. Rather than someone who could help the company and have a qualified member he rather protect his free income of money flow. Two years and still waiting for him to get to the bottom of the botched trials Mgmt and the BOD must be laughing their way to the bank. The news of all the preclinical trials just insures they they will be collected salaries bonuses and free options for years to come regardless if patients are dying or if more trials are botched. As usual it is a win win for the BOD and mgmt all at the expense of shareholders and patients. All imo.
News 
Market Data 
Discover 
AI
